Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome
NCT ID: NCT00213434
Last Updated: 2013-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2001-11-30
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea
NCT02112435
Comparison of Two Oral Appliances in the Treatment of Sleep Apnea Syndrome
NCT02763813
Clinial Study of Treatment With Mandibular Advancement Device in Patients With Obstructive Sleep Apnea Across 6 General Hospitals
NCT06837285
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
NCT05939934
Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance
NCT06576310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Herbst oral appliance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) \< 35 Kg/m2
* Able to give their informed consent
Exclusion Criteria
* Professional drivers requiring continuous positive airway pressure (CPAP) treatment
* Psychiatric disorders, and patients unable to realise to study
* Severe respiratory pathology which could interfere with the study
* Morpheic epilepsy
* Benzodiazepines intake
* Chronic nasal obstruction
* Ear, nose, and throat (ENT) pathology requiring surgery
* Previous uvulopalatoplasty surgery
* Temporomandibular joint pathology
* Gum disease
* Insufficient number of teeth to apply the oral appliance
* Mobile teeth
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PORTIER PF Florence, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de ROUEN
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000/055/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.